JSR and SymBiosis took part in an $18.5m series C extension for PureTech spinoff Vedanta, growing the Bristol-Myers Squibb and PureTech Health-backed round to $45.5m.

Warf-backed 4490 Ventures has returned to supply funding to weather analytics service Understory in support of the latter’s international expansion and recruitment strategy.

The series A, led by corporate venturing unit GV, may not have been last week’s largest deal, but Verve’s tie-up with fellow Harvard spinout Beam Therapeutics tells an intriguing story.

JD.com has secured CICC Capital, Baring Private Equity Asia and CPEChina Fund for a series A round expected to value its healthcare spinoff at $6.9bn.

SoftBank Vision Fund is investing $800m in Greensill, a platform that provides working capital to businesses, at a reported $3.5bn valuation.

Qihoo 360 spinoff Beijing Qianxin Technology has received approximately $542m from China Electronics Corporation at a valuation of $2.4bn.

The Posco-backed pulmonary device maker has collected $65m in an oversubscribed round led by Ally Bridge Group, taking its equity funding to $135m to date.

The Optum-backed round was led by Leerink Transformation Partners and will fund the home medical test provider's international expansion plans.

Hanwha Asset Management contributed to a round that boosted the online life insurance provider's overall funding to about $140m.

Samurai Incubate Fund VI, backed by corporates such as Keikyu, Mitsui Sumitomo Insurance and Seino Holdings, is set to start accepting applications for the second edition of The First Movers program.